People People

People

Kevin Sharara Baker Botts Dubai
Kevin Sharara Baker Botts Dubai
Kevin Sharara
Associate
[email protected]
DETAILS
Practices
Artificial Intelligence
Corporate
Corporate Venture Capital
Emerging Companies and Venture Capital
Privacy and Cybersecurity
Sourcing
Technology Transactions
Industries
Technology
Details
Overview
Overview Admissions & Affiliations Experience Thought Leadership
Practices
Artificial Intelligence
Corporate
Corporate Venture Capital
Emerging Companies and Venture Capital
Privacy and Cybersecurity
Sourcing
Technology Transactions
Industries
Technology

Overview

Kevin Sharara is an Associate based in the firm's Dubai office.

Kevin is a commercial lawyer who is skilled in crafting and negotiating complex commercial arrangements, including in relation to technology development, licensing and outsourcing. He also regularly advises in connection with corporate transactions involving IP-rich companies, and on various regulatory issues (with a focus on data protection and cybersecurity matters).

Kevin has advised clients in a variety of sectors, with a particular focus on the technology and life sciences sectors.

He has previously worked with companies at all stages of growth (from seed round to exit), and with the investors financing them.

Kevin trained as a lawyer with a major UK law firm, and previously practiced in the London office of a leading U.S. law firm as an associate in the Technology Transactions team. Kevin has also spent some time as in-house legal counsel for a Dubai-based technology company.

Admissions & Affiliations

  • Qualified Solicitor, England & Wales, 2018

Education

  • Legal Practice Course, Commercial Law, BPP Law School 2014
  • Bachelor of Laws, Université Catholique de Lille 2011
    honours

Experience

Kevin's experience includes advising:

  • the developer of a boundary-pushing AI-powered national security technology on the protection of its intellectual property and the licensing of its technology to large organisations and governmental entities, and on related data protection issues.*
  • the developer of a drug discovery AI model on licensing access to its technology to large pharma groups.*
  • a world-leading manufacturer of consumer products on procuring business-critical IT services for its factories in 41 countries from six different suppliers.*
  • a market-leading payments processor on a number of data protection matters, including on international data transfer restrictions and on responding to investigations by regulators in various jurisdictions.*
  • many of the world's leading venture capital firms (including Andreessen Horowitz, Sequoia Capital and Accel) on their investment in UK and EU companies.*
  • a large number of early-stage companies (from seed round to Series D round) in connection with a variety of commercial contracts, consumer terms, product launches and regulatory matters.*

* prior to joining Baker Botts